Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01553097 · ClinicalTrials.gov registry record
Examining a Common Complaint of Women Who Receive Chemotherapy for Breast Cancer- Cognitive Difficulty
A clinical trial, sponsored by Virginia Commonwealth University.
- Completed
- Registry status
- 51
- Enrollment target
NCT01553097: Completed study, sponsored by Virginia Commonwealth University.
NCT01553097 is a clinical trial that has completed, run by Virginia Commonwealth University. The registered enrollment target is 51 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01553097 has completed, sponsored by Virginia Commonwealth University.
- COMPLETED
- Registry status
- 51 participants
- Enrollment target
Study Summary
This longitudinal project will investigate a common complaint of women who receive chemotherapy for breast cancer- cognitive difficulty. The relationships of fatigue, stress, and depression to cognitive difficulties will be examined. The findings should lead to interventions to decrease the effects of these problematic side effects.
Interventions
- OTHER Neurocognitive impairment observation
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 51 participants |
| Start Date | 2012-03 |
| Est. Completion | 2014-05 |
What the finished NCT01553097 record still lists
NCT01553097 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 51 participants, a relatively small participant target.
The record links to 0 conditions, and to 1 intervention - of which Neurocognitive impairment observation is the first listed.
NCT01553097 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01553097 about?
NCT01553097 is a clinical study titled "Examining a Common Complaint of Women Who Receive Chemotherapy for Breast Cancer- Cognitive Difficulty". This longitudinal project will investigate a common complaint of women who receive chemotherapy for breast cancer- cognitive difficulty. The relationships of fatigue, stress, and depression to cognitive difficulties will be examined. The findings should lead to interventions to decrease the effects ...
What is the current status of trial NCT01553097?
This trial is currently completed. The enrollment target is 51 participants. The study started on 2012-03. Estimated completion is 2014-05.
What interventions are being tested in trial NCT01553097?
The interventions under investigation include: Neurocognitive impairment observation (OTHER).
Who is sponsoring clinical trial NCT01553097?
This trial is sponsored by Virginia Commonwealth University, which has 558 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02701153 · 51 participants · NA
Phase II Study of 5-Day Hypofractionated Preoperative Radiation Therapy for Soft Tissue Sarcomas: Expansion Cohort
- NCT03663790 · 51 participants · NA
Effects of Gait Retraining on Lower Extremity Biomechanics
- NCT03874052 · 51 participants · Phase 1
Ruxolitinib in Combination With Venetoclax With and Without Azacitidine in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia
- NCT04704661 · 51 participants · Phase 1
Testing the Combination of Two Anti-cancer Drugs, DS-8201a and AZD6738, for The Treatment of Advanced Solid Tumors Expressing the HER2 Protein or Gene, The DASH Trial
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia